Company Filing History:
Years Active: 2012-2014
Title: Innovations by Choi Sungwoon in Neurodegenerative Disease Treatment
Introduction
Choi Sungwoon is an accomplished inventor based in Sharon, MA (US). She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of therapeutic compounds. With a total of 2 patents, her work focuses on improving the treatment and imaging of dopamine neurons.
Latest Patents
Choi's latest patents include the development of diagnostic and therapeutic alkyl piperidine/piperazine compounds. These compounds are designed to treat neurodegenerative diseases characterized by a lack of dopamine neuron activity. The patents describe piperidine and piperazine compounds that are not only useful for treating these conditions but also for imaging dopamine neurons. The compounds are characterized by specific formulae that include various functional groups, enhancing their therapeutic potential.
Career Highlights
Choi Sungwoon is affiliated with The General Hospital Corporation, where she continues to advance her research in neurodegenerative diseases. Her work has garnered attention for its potential to significantly impact the treatment landscape for conditions related to dopamine neuron dysfunction.
Collaborations
Choi collaborates with esteemed colleagues such as David R Elmaleh and Alan J Fischman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Choi Sungwoon's contributions to the field of neurodegenerative disease treatment through her patented innovations highlight her role as a leading inventor. Her work not only addresses critical medical needs but also paves the way for future advancements in the treatment of these challenging conditions.